Acoustic Assessment of Nebulized Epinephrine Versus Albuterol for RSV Bronchiolitis- a Double Blind Study
|Rsv Bronchiolitis||Drug: nebulized epinephrine and nebulized albuterol||Phase 4|
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Primary Purpose: Treatment
|Official Title:||Acoustic Assessment of Nebulized Epinephrine Versus Albuterol for RSV Bronchiolitis- a Double Blind Study|
- respiratory clinical score
- computerized quantification of wheezing and crackles
|Study Start Date:||December 2000|
|Estimated Study Completion Date:||May 2001|
Inpatient Infants younger than 2 years of age with first episode of RSV bronchiolitis will be randomly assigned to treatment with nebulized epinephrine (1 mg diluted with 3 ml of 0.9% saline) or nebulized albuterol (2.5 mg diluted with 3.5 ml of 0.9% saline). Both solutions will be provided in identical containers.
Clinical assessment and clinical score will be done before treatment, 10 and 30 minutes after treatment. The following parameters were recorded at each time point, wheezing, respiratory distress, O2 saturation, respiratory rate and heart rate. Computerized lung sounds as well, will be recorded before treatment, 10 and 30 minutes after treatment via 4 contact sensors attached to the chest.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00361452
|Pediatric Ward, Rambam Medical Centre|
|Haifa, Israel, 31096|
|Principal Investigator:||LEA BENTUR, MD||Rambam medical centre, pediatric pulmonary unit, HAIFA|